PEAR

Pear Therapeutics, Inc. Class A Common Stock

Delisted

PEAR was delisted on the 18th of April, 2023.

18 hedge funds and large institutions have $26.9M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
18
Holders Change
+18
Holders Change %
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Citadel Advisors
1
Citadel Advisors
Florida
$6.87M 715,895 +715,895 New
SCM
2
Saba Capital Management
New York
$6.38M 665,095 +665,095 New
UOC
3
UBS O'Connor
Illinois
$2.4M 249,991 +249,991 New
OCM
4
Oribel Capital Management
New York
$2.05M 212,356 +212,356 New
SC
5
Sculptor Capital
New York
$1.93M 199,998 +199,998 New
Verition Fund Management
6
Verition Fund Management
Connecticut
$1.74M 181,150 +181,150 New
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$1.45M 150,000 +150,000 New
FTCM
8
Fir Tree Capital Management
New York
$959K 100,000 +100,000 New
HI
9
HBK Investments
Texas
$676K 69,948 +69,948 New
WA
10
Whitebox Advisors
Minnesota
$482K 50,300 +50,300 New
CH
11
CVI Holdings
Delaware
$480K 50,000 +50,000 New
Goldman Sachs
12
Goldman Sachs
New York
$382K 39,540 +39,540 New
Jane Street
13
Jane Street
New York
$241K 24,900 +24,900 New
ACM
14
Atalaya Capital Management
New York
$240K 25,000 +25,000 New
VI
15
Vestcor Inc
New Brunswick, Canada
$240K 25,000 +25,000 New
DCM
16
DG Capital Management
New York
$240K 25,000 +25,000 New
OCAM
17
Owl Creek Asset Management
New York
$121K 12,498 +12,498 New
BCM
18
Basso Capital Management
Connecticut
$1K 100 +100 New
CFGS
19
Concourse Financial Group Securities
Alabama